** Shares of medical device maker AngioDynamics ANGO.O rise 31.6% to $12.37
** ANGO now expects 2025 adj. loss per share between $0.34 and $0.38, down from its prior projection of between $0.38 and $0.42
** Company continues to expect net sales in the range of $282 mln to $288 mln
** Posts Q2 net sales of $73 mln, up 9.2%
** Stock had risen ~17% in 2024
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。